NEW YORK, August 1 – Transgenomic reported second quarter revenues of $9.5 million, up 71 percent from the comparable period a year ago, on the back of rising sales of consumables supplied by its recently acquired subsidiary Annovis, Transgenomic said Wednesday. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.